Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · IEX Real-Time Price · USD
3.900
-0.020 (-0.51%)
At close: Jul 26, 2024, 4:00 PM
3.950
+0.050 (1.28%)
After-hours: Jul 26, 2024, 5:51 PM EDT
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $736.00 million as of July 26, 2024. Its market cap has increased by 95.17% in one year.
Market Cap
736.00M
Enterprise Value
608.44M
1-Year Change
95.17%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $736.00M, an increase of 1,449.47%. That is a compound annual growth rate of 20.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 739.80M | 76.48% |
| Dec 29, 2023 | 419.20M | 14.98% |
| Dec 30, 2022 | 364.60M | -30.71% |
| Dec 31, 2021 | 526.20M | 74.59% |
| Dec 31, 2020 | 301.40M | 90.76% |
| Dec 31, 2019 | 158.00M | -25.65% |
| Dec 31, 2018 | 212.50M | -23.56% |
| Dec 29, 2017 | 278.00M | 106.85% |
| Dec 30, 2016 | 134.40M | -44.65% |
| Dec 31, 2015 | 242.80M | -28.19% |
| Dec 31, 2014 | 338.10M | 196.58% |
| Dec 31, 2013 | 114.00M | 89.05% |
| Dec 31, 2012 | 60.30M | 289.03% |
| Dec 30, 2011 | 15.50M | -68.04% |
| Dec 31, 2010 | 48.50M | 2.11% |
| Dec 31, 2009 | 47.50M | - |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abivax | 757.53M |
| Travere Therapeutics | 744.54M |
| Zymeworks | 733.92M |
| Scholar Rock Holding | 733.74M |
| Savara | 733.38M |
| Weave Communications | 720.48M |
| Alumis | 710.26M |
| Phathom Pharmaceuticals | 710.03M |